- Induction of labor using one dose vs multiple doses of misoprostol – A randomized controlled trial
- Use of antiepileptic drugs and dementia risk: An analysis of Finnish health register and German health insurance data
- Direct-acting antiviral treatment for hepatitis C virus infection and risk of incident liver cancer: A retrospective cohort study
- A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results
- The impact of anxiety and catastrophizing on interleukin-6 responses to acute painful stress
- Effect of spironolactone on myocardial fibrosis and other clinical variables in patients with hypertrophic cardiomyopathy: A prospective, randomized trial
- Disease-modifying drugs for multiple sclerosis and infection risk: A cohort study
- Antibiotic resistance evolution of <em>Pseudomonas aeruginosa</em> in cystic fibrosis patients (2010-2013)
- A controlled pilot trial of PainTracker Self-Manager, a web-based platform combined with patient coaching, to support patients' self-management of chronic pain
- Nivolumab for relapsed/refractory classic Hodgkin lymphoma after failure of autologous hematopoietic cell transplantation: Extended follow-up of the multicohort single-arm phase II CheckMate 205 trial
- Ibrutinib plus venetoclax for the treatment of mantle-cell lymphoma
- Rituximab vs the modified ponticelli regimen in the treatment of primary membranous nephropathy: A health economic model
- Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: Phase 1 results from a multicentre, open-label, phase 1/2 study
- Duration of adjuvant chemotherapy for stage III colon cancer
- Effectiveness and safety of outpatient rivaroxaban vs warfarin for treatment of venous thromboembolism in patients with a known primary hypercoagulable state
Feed Sources
